Visceral injury and systemic inflammation in patients undergoing extracorporeal circulation during aortic surgery

Annals of Surgery

Volumn 248, Issue 1, 2008, Pages 117-125

  Hanssen, Sebastiaan J ^a,b,c   Derikx, Joep P ^a,b   Vermeulen Windsant, Iris C ^a,b,c   Heijmans, John H ^b   Koeppel, Thomas A ^c   Schurink, Geert Willem ^b,c,d   Buurman, Wim A ^a,b   Jacobs, Michael J ^b,c,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; FABP1 PROTEIN, HUMAN;

ADULT; ANEURYSM SURGERY; AORTA ANEURYSM; AORTA SURGERY; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTESTINE; INTESTINE INJURY; INTESTINE PERFUSION; KIDNEY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORACIC AORTA ANEURYSM; VISCERA; AREA UNDER THE CURVE; BLOOD; INJURY; INTESTINE MUCOSA; MIDDLE AGED; VASCULARIZATION;

AORTIC ANEURYSM, THORACIC; AREA UNDER CURVE; EXTRACORPOREAL CIRCULATION; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; MIDDLE AGED; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VISCERA;

EID: 48949118941     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181784cc5     Document Type: Article

References (36)

1. Rectenwald JE, Huber TS, Martin TD, et al. Functional outcome after thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2002;35:640- 647.
2. Gloviczki P. Surgical repair of thoracoabdominal aneurysms: patient selection, techniques and results. Cardiovasc Surg. 2002;10:434-441.
3. Achouh PE, Madsen K, Miller CC III, et al. Gastrointestinal complications after descending thoracic and thoracoabdominal aortic repairs: a 14-year experience. J Vasc Surg. 2006;44:442-446.
4. Fink MP. Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med. 1991;19:627-641.
5. Moore FA. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg. 1999;178:449-453.
6. MacArthur RG, Carter SA, Coselli JS, et al. Organ protection during thoracoabdominal aortic surgery: rationale for a multimodality approach. Semin Cardiothorac Vasc Anesth. 2005;9:143-149.
7. Welborn MB, Oldenburg HS, Hess PJ, et al. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit CareMed. 2000;28:3191-3197.
8. Jacobs MJ, de Mol BA, Legemate DA, et al. Retrograde aortic and selective organ perfusion during thoracoabdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 1997;14:360 -366.
9. Jacobs MJ, Mommertz G, Koeppel TA, et al. Surgical repair of thora- coabdominal aortic aneurysms. J Cardiovasc Surg (Torino). 2007;48:49 -58.
10. Takala J. Determinants of splanchnic blood flow. Br J Anaesth. 1996;77:50-58.
11. Ohri SK, Somasundaram S, Koak Y, et al. The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass. Gastroenterology. 1994;106:318-323.
12. Riddington DW, Venkatesh B, Boivin CM, et al. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. Jama. 1996;275:1007-1012.
13. Rossi M, Sganga G, Mazzone M, et al. Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation. Ann Thorac Surg. 2004;77:612-618.
14. Holmes JHT, Lieberman JM, Probert CB, et al. Elevated intestinal fatty acid binding protein and gastrointestinal complications following car- diopulmonary bypass: a preliminary analysis. J Surg Res. 2001;100:192-196.
15. Bolcal C, Iyem H, Sargin M, et al. Gastrointestinal complications after cardiopulmonary bypass: Sixteen years of experience. Can J Gastroen- terol. 2005;19:613-617.
16. Sato K, Sogawa M, Namura O, et al. Deterioration of body oxygen metabolism by vasodilator and/or vasoconstrictor administration during cardiopulmonary bypass. Asaio J. 2006;52:96-99.
17. Morariu AM, Loef BG, Aarts LP, et al. Dexamethasone: benefit and prejudice for patients undergoing on -pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest. 2005;128:2677-2687.
18. Crawford ES. Thoraco- abdominal and abdominal aortic aneurysms involving renal, superior mesenteric, celiac arteries. Ann Surg. 1974;179:763-772.
19. Jacobs MJ, Eijsman L, Meylaerts SA, et al. Reduced renal failure following thoracoabdominal aortic aneurysm repair by selective perfu- sion. Eur J Cardiothorac Surg. 1998;14:201-205.
20. Lieberman JM, Sacchettini J, Marks C, et al. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997;121:335-342.
21. Niewold TA, Meinen M, van der Meulen J. Plasma intestinal fatty acid binding protein (I-FABP) concentrations increase following intestinal ischemia in pigs. Res Vet Sci. 2004;77:89-91.
22. Pelsers MM, Namiot Z, Kisielewski W, et al. Intestinal-type and liver- type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;36:529-535.
23. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352:15-35.
24. Ytting H, Christensen IJ, Basse L, et al. Influence of major surgery on the mannan -binding lectin pathway of innate immunity. Clin Exp Immunol. 2006;144:239-246.
25. Fiane AE, Videm V, Lingaas PS, et al. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation. 2003;108:849-856.
26. Dentener MA, Bazil V, Von Asmuth EJ, et al. Involvement of CD14 in lipopolysaccharide -induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol. 1993;150:2885-2891.
27. Derikx JP, Poeze M, van Bijnen AA, et al. Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock. 2007;28:544-548.
28. Laschinger JC, Cunningham JN Jr, Nathan IM, et al. Experimental and clinical assessment of the adequacy of partial bypass in maintenance of spinal cord blood flow during operations on the thoracic aorta. Ann Thorac Surg. 1983;36:417-426.
29. Kazui T, Yamada O, Ito T, et al. [Total graft replacement of the thoracoabdominal aorta with reconstruction of visceral branches, intercostal and lumbar arteries in expanding chronic dissecting aneurysms of the thoracoabdominal aorta.] Nippon Kyobu Geka Gakkai Zasshi. 1989; 37:1436-1440.
30. Bailey RW, Bulkley GB, Hamilton SR, et al. Pathogenesis of nonoc- clusive ischemic colitis. Ann Surg. 1986;203:590 -599.
31. Krejci V, Hiltebrand LB, Erni D, et al. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med. 2003;31:203-210.
32. Sautner T, Wessely C, Riegler M, et al. Early effects of catecholamine therapy on mucosal integrity, intestinal blood flow, and oxygen metabolism in porcine endotoxin shock. Ann Surg. 1998;228:239-248.
33. Gunel E, Caglayan F, Caglayan O, et al. Treatment of intestinal reper- fusion injury using antioxidative agents. J Pediatr Surg. 1998;33:1536 -1539.
34. Udassin R, Haskel Y, Samuni A. Nitroxide radical attenuates ischaemia/ reperfusion injury to the rat small intestine. Gut. 1998;42:623-627.
35. Idu MM, Heintjes RJ, Scholten EW, et al. Visceral and renal tissue oxygenation during supraceliac aortic crossclamping and left heart bypass with selective organ perfusion. Eur J Vasc Endovasc Surg. 2004;27:138-144.
36. Leijdekkers VJ, Wirds JW, Vahl AC, et al. The visceral perfusion system and distal bypass during thoracoabdominal aneurysm surgery: an alternative for physiological blood flow? Cardiovasc Surg. 1999;7:219-224.